VanEck Associates’s Viking Therapeutics VKTX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-14,911	Closed	-$600K	–	1410
2024 Q4	$600K	Buy	14,911 +5,475	+58%	+$220K	﹤0.01%	1112
2024 Q3	$570K	Sell	9,436 -6,843	-42%	-$413K	﹤0.01%	1074
2024 Q2	$863K	Buy	+16,279	New	+$863K	﹤0.01%	1007